Even international bans will fail – at best they can deal with states – no matter how effective there will be private / rogue gaps.
Scott J. Schweikart, Global Regulation of Germline Genome Editing: Ethical Considerations and Application of International Human Rights Law, 43 Loy. L.A. Int'l & Comp. L. Rev. 279 (2021). Available at: https://digitalcommons.lmu.edu/ilr/vol43/iss3/6
Lastly, it is important to remember that any global governance structure that comes from a treaty or declaration is only intended to bind or influence individual nation-states, assuming that parties to such treaties would use their own national legal framework to enforce relevant matters in their jurisdiction. However, the relevant matters that national governments generally tackle are not always easily enforceable or identifiable in this rapidly changing world of bio-medical advancements. For example, there is already a growing movement of DIY-Bio or “bio-hackers,” who are buying CRISPR kits and are doing genetic modifications at home, outside of the knowledge or purview of any government agency or regulatory authority.95 Under such circumstances, even if a government follows international human rights law to regulate germline genome editing, it may only have influence over the traditional users of biomedical technology, i.e., corporations and university medical centers. No matter how effective any form of international oversight may be, gaps will remain in policing the ethical practice of germline genome editing